Terapia Génica en Enfermedades Neurológicas
![Foto de Terapia Génica en Enfermedades Neurológicas](/img/uploaded/6def07e525c170a080dc073bfff032fc.jpg)
![Foto de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas](/img/noimage_org.png)
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (6)
2014
-
Phosphodiesterase inhibition in cognitive decline
Journal of Alzheimer's Disease, Vol. 42, pp. S561-S573
2013
-
Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD
Neuropharmacology, Vol. 64, pp. 114-123
2012
-
Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease
Hippocampus, Vol. 22, Núm. 5, pp. 1040-1050
2011
-
Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in alzheimer's disease transgenic mice: An insight into the pathogenic effects of amyloid-β
Journal of Alzheimer's Disease, Vol. 23, Núm. 2, pp. 195-206
2009
-
Early changes in hippocampal eph receptors precede the onset of memory decline in mouse models of alzheimer's disease
Journal of Alzheimer's Disease, Vol. 17, Núm. 4, pp. 773-786
-
Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels
Neurobiology of Disease, Vol. 33, Núm. 3, pp. 369-378